摘要 |
The present invention relates to crystalline Form A of 1-[(3R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-2H-imidazole-2-thione and crystalline Form B of 1-[(3R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-2H-imidazole-2-thione, processes for preparing the forms and their uses in medicine. The present invention also relates to the amorphous form of 1-[(3R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-2H-imidazole-2-thione processes for preparing it and its uses in medicine. |
申请人 |
BIAL - PORTELA & CA., S.A.;BELIAEV, ALEXANDER;LEARMONTH, DAVID, ALEXANDER;BROADBELT, BRIAN;ALBERT, EKATERINA;ANDRES, PATRICIA |
发明人 |
BELIAEV, ALEXANDER;LEARMONTH, DAVID, ALEXANDER;BROADBELT, BRIAN;ALBERT, EKATERINA;ANDRES, PATRICIA |